STAAR Surgical Appoints Scott Barnes, MD, as New CMO

October 6, 2017: By Jon Swedien

STAAR Surgical logoSTAAR Surgical has appointed Scott D. Barnes, MD, to be its chief medical officer, a newly created position, the Monrovia, California, company announced Oct. 2.

Barnes will report to Caren Mason, STAAR’s president and CEO.

He will also serve on the executive management team and provide strategic guidance for STAAR’s medical affairs, professional affairs, and product development pathways. As well, Barnes will lead the company’s surgeon training, certification programs, and surgeon working groups, STAAR said.

Since 2012, Barnes has served as chief of ophthalmology services at Womack Army Medical Center in Fort Bragg, North Carolina.

Barnes has personally implanted more than 3,000 implantantable contact lenses in the eyes of soldiers, STAAR said.

He joined Womack in 2004 as chief of ophthalmology and refractive surgery and served as a theater ophthalmology consultant in Iraq and Afghanistan during 2005. In 2006, he returned to Womack as chief of refractive surgery, and, in 2008, he was designated Army Surgeon General A, which is similar to the professor level in a civilian institution.

Need Deeper Analysis? Sign up for Market Scope's monthly newsletter to get in-depth coverage of the ophthalmic market, including quarterly procedure volumes based on survey data and meeting coverage from around the world.

Recent Ophthalmic News

Carl Zeiss Meditec Announces Milestone of 1.5 Million SMILE Procedures

Heidelberg Gains US Clearance for OCT Angiography Module

ASCRS Convenes Task Force to Study CyPass Data, Make Recommendations

Bascom Palmer Treats First US Patient in Nightstar’s Trial for X-Linked Retinitis Pigmentosa

First Patient Treated in Allotex’ Trial for Allogenic Refractive Lenticules for Presbyopia

Bausch + Lomb Announces Positive Results for Loteprednol Etabonate Gel

LumiThera Set to Launch Valeda Light Delivery System for Dry AMD

Kodiak Sciences Names Jason Ehrlich, MD, PhD, Chief Medical Officer

Second Sight Receives $1.6 Million Grant from NIH to Support Orion Program

Regeneron to Invest $800 Million in New York Campus

American Women Raise Funds for Nepal Mission to Reduce Corneal Blindness

Ziemer to Add Lenticule Extraction Capabilities to LDV Z8

Stealth BioTherapeutics Raises $100 Million in Support of Elamipretide for Dry AMD

STAAR Gains US Approval of Visian Toric ICL

Sun Pharma, SPARC Announce FDA Approval for Xelpros for Open-Angle Glaucoma, Ocular Hypertension

FDA Will Review Regeneron’s Submission to Expand Eylea’s Labeling to All DR Patients

Alcon Will Locate Headquarters in Switzerland

Kodiak Sciences Files for $100 Million IPO

Iridex Announces $10 Million Public Offering

Oxford BioMedica Expands Capacity with New Facility